Objective To study the causal effect between plasma proteins and HIV infection by two⁃sample Mendelian randomization (MR) analysis, so as to explore potential therapeutic targets for HIV infection. Methods Protein quantitative trait loci (pQTLs) were obtained from genome⁃wide association studies (GWAS) datasets acquired based on the Icelandic Cancer Project and the deCODE project, and HIV infection samples were obtained from GWAS database of the IEU OpenGWAS Project. Plasma proteins were used as the exposure factor, HIV infection as the outcome, and cis⁃pQTLs related to plasma protein expressions were used as instrumental variables. After screening for qualified variable instruments, the two⁃sample bidirectional MR analyses were performed by using inverse variance weighting. The Cochran's Q test, MR⁃Egger intercept test, and leave⁃one⁃out analysis were adopted to perform sensitivity analysis. For plasma proteins screened by MR analysis, Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed based on the R language software, and their interactions with drugs were analyzed by employing the DGIdb database. THP⁃1 cells were assigned to experiment group (adding HIV⁃189.6) or control group. The real⁃time fluorescent quantitative PCR was adopted to detect mRNA expressions of relevant genes for validating the results of MR analyses. Results A total of 4144 cis⁃pQTLs related to 1394 plasma proteins were enrolled for MR analyses. The results of MR analyses suggested that 18 plasma proteins were related to HIV infection, of which 9 were protective factors and 9 were risk factors. The results of sensitivity analysis revealed that there was no heterogeneity and horizontal pleiotropy of causal effect between plasma proteins as above and HIV infection. The results of enrichment analyses indicated that the aforementioned plasma proteins are significantly enriched in biological processes such as phagocytosis and recognition, apoptotic cell clearance, and in pathways related to immune diseases (P<0.05). Druggability assessment depicted that 5 of these proteins had been targeted for drug development. Compared to the control group, the experiment group exhibited up⁃regulated mRNA expression of SIGLEC14 in THP⁃1⁃derived macrophages, whereas down⁃regulated mRNA expressions of LEAP2 and SERPINA4 (P<0.05). Conclusion The identified HIV infection⁃related protein markers may use as potential diagnostic biomarkers and drug targets, and provide a new perspective for the treatment of HIV infection.